RMO No. 40-2024: New 25% ATC Mapping for Dividends and Other Payments to Non-Resident Foreign Corporations

RMO No. 40-2024 modifies ATCs WC212, WC213, and WC230 for NRFC payments, aligning selected final withholding tax reporting with a 25% rate. Domestic corporations paying dividends or other covered income to non-resident foreign corporations must immediately review their BIR Form 1601-FQ and BIR Form 2306 reporting because RMO No. 40-2024 modifies the applicable Alphanumeric Tax […]

RMC No. 5-2022: FDA-Endorsed Updates to VAT-Exempt Products List for Medicines and Health Items

RMC No. 5-2022 republishes the FDA-endorsed updates to VAT-exempt products, affecting businesses handling medicines for kidney diseases. Immediate compliance is required. Businesses handling medicines for kidney diseases and related health products must update their VAT exemption practices immediately. RMC No. 5-2022 republishes the Food and Drug Administration’s letter endorsing updates to the list of VAT-exempt […]

RMC No. 2-2022: Updated VAT-Exempt COVID-19 Medicines Endorsed by DOH for Philippine Tax Compliance

RMC No. 2-2022 updates the list of VAT-exempt COVID-19 medicines under RA 11534, affecting pharmacies, hospitals, and suppliers. Businesses must adjust VAT treatment immediately. Businesses must now ensure their VAT compliance reflects the latest list of COVID-19 medicines that are exempt from value-added tax under Republic Act No. 11534. The Department of Health has officially […]

RMC No. 115-2021: Endorsement of Updated VAT-Exempt COVID-19 Medicines List Under RA 11534

RMC No. 115-2021 endorses the updated list of VAT-exempt COVID-19 vaccines and drugs under RA 11534. Businesses must apply VAT exemption immediately and maintain proper documentation. Businesses and healthcare providers must immediately take note of the updated VAT-exempt status for certain COVID-19 medicines under Republic Act No. 11534 (Corporate Recovery and Tax Incentives for Enterprises, […]

RMC No. 89-2021: Key Guidelines on Corporate Income Tax Reform and CREATE Act Compliance

RMC No. 89-2021 provides official BIR guidance on the CREATE Act, outlining new corporate tax rates, incentives, and compliance requirements for Philippine corporations. Businesses in the Philippines must immediately adapt to the new corporate income tax framework under Republic Act No. 11534, known as the Corporate Recovery and Tax Incentives for Enterprises (CREATE) Act. This […]

RR No. 3-2021: DOF Access to BIR Tax Information for CREATE Act Incentives Review

RR No. 3-2021 lets the DOF obtain BIR tax information on CREATE Act incentive recipients, requiring companies to align filings, records, and incentive claims. Enterprises enjoying or applying for tax incentives under the CREATE Act should expect closer coordination between the Department of Finance and the Bureau of Internal Revenue. RR No. 3-2021 allows the […]